Suppr超能文献

肝炎相关抗原阳性患者的细胞介导免疫

Cell-mediated immunity in patients positive for hepatitis-associated antigen.

作者信息

Dudley F J, Giustino V, Sherlock S

出版信息

Br Med J. 1972 Dec 30;4(5843):754-6. doi: 10.1136/bmj.4.5843.754.

Abstract

Cell-mediated immunity to antigens prepared from both serum and liver of patients positive for hepatitis-associated antigen (H.A.A.) was measured by using the leucocyte migration test. Altogether, 43 patients with H.A.A.-positive acute and chronic liver disease, eight with serum antibody to H.A.A., and 13 controls were studied. The cell-mediated immunity detected was specific for H.A.A. or other antigenic determinants of the associated infective agent and could be found only in patients with evidence of previous contact with H.A.A.Cell-mediated immunity to the H.A.A.-positive test antigens was found in all but one of the patients with acute hepatitis, in about half of the patients with chronic aggressive hepatitis or cirrhosis, rarely in those with chronic persistent hepatitis, and in none of the apparently healthy carriers.Our results support the hypothesis that the cellular immune response plays an important part in the clearance of the infective agent from H.A.A.-positive patients and in the pathogenesis of the associated liver cell injury.

摘要

采用白细胞游走试验测定了对从肝炎相关抗原(H.A.A.)阳性患者的血清和肝脏制备的抗原的细胞介导免疫。总共研究了43例H.A.A.阳性的急性和慢性肝病患者、8例具有H.A.A.血清抗体的患者以及13名对照。检测到的细胞介导免疫对H.A.A.或相关感染因子的其他抗原决定簇具有特异性,并且仅在有先前接触H.A.A.证据的患者中发现。除1例急性肝炎患者外,所有急性肝炎患者均发现了对H.A.A.阳性试验抗原的细胞介导免疫,约一半慢性侵袭性肝炎或肝硬化患者有此免疫,慢性持续性肝炎患者中很少见,而明显健康的携带者中未发现。我们的结果支持这样的假说,即细胞免疫反应在从H.A.A.阳性患者清除感染因子以及相关肝细胞损伤的发病机制中起重要作用。

相似文献

引用本文的文献

1
Beasley's 1981 paper: The power of a well-designed cohort study to drive liver cancer research and prevention.
Cancer Epidemiol. 2018 Apr;53:195-199. doi: 10.1016/j.canep.2018.01.007. Epub 2018 Feb 13.
3
The immunopathology of acute type B hepatitis.
Springer Semin Immunopathol. 1981 Apr;3(4):421-38. doi: 10.1007/BF01951491.
5
Enhancement by murabutide of the immune response to natural and synthetic hepatitis B surface antigens.
Infect Immun. 1984 Jul;45(1):261-6. doi: 10.1128/iai.45.1.261-266.1984.
6
Immunosuppressive treatment of chronic HBsAg-positive hepatitis in childhood.
Infection. 1983 Sep-Oct;11(5):255-9. doi: 10.1007/BF01641256.
9
10
The immunopathogenesis of chronic HBV induced liver disease.
Springer Semin Immunopathol. 1981 Apr;3(4):439-59. doi: 10.1007/BF01951492.

本文引用的文献

1
Human lymphocyte migration as a parameter of hypersensitivity.
Acta Med Scand. 1967 Feb;181(2):247-56. doi: 10.1111/j.0954-6820.1967.tb07255.x.
2
Chronic hepatitis--migration inhibition of leukocytes in the presence of Australia antigen.
N Engl J Med. 1972 May 4;286(18):1005. doi: 10.1056/nejm197205042861817.
4
Relation of Australia-SH antigen to the willowbrook MS-2 strain.
N Engl J Med. 1969 Jul 17;281(3):119-22. doi: 10.1056/NEJM196907172810302.
7
Viral hepatitis. New light on an old disease.
JAMA. 1970 May 11;212(6):1019-29. doi: 10.1001/jama.212.6.1019.
8
Hepatitis-associated antigen in chronic liver disease.
Lancet. 1969 Sep 20;2(7621):609-12. doi: 10.1016/s0140-6736(69)90324-9.
9
Cellular immunity and hepatitis-associated, Australia antigen liver disease.
Lancet. 1972 Apr 1;1(7753):723-6. doi: 10.1016/s0140-6736(72)90234-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验